by The global skin boosters market size was valued at USD 935.2 million in 2020, and is predicted to be worth around USD 2.2 billion by 2030, registering a CAGR of 9.2% during the forecast period 2022 to 2030.
Download Exclusive Sample of Report@ https://www.visionresearchreports.com/report/sample/39150
Table of Contents
Skin Boosters Market Growth Factors
Skin Boosters is a procedure wherein microinjections of biocompatible compounds like hyaluronic acid, vitamins, minerals, anti-oxidants, etc. that are naturally produced by the body are injected into the epidermis or mesoderm. Skin boosters simply help aid in the hydration process, which is fundamental for a youthful glow.
The desire to look youthful among the millennials and rising consumption of aesthetic procedures by both men and women, especially from the emerging economies are majorly estimated to drive the market. However, the advent of the COVID-19 pandemic has hugely affected the overall non-invasive aesthetic industry. But many aesthetic professionals believe that pandemics might most likely propel the overall aesthetic market. Many dermatology clinics have witnessed a boost in the number of future appointments and consultations for different skin treatments and this is expected to boost the market growth.
The demand for skin boosters is expected to propel significantly due to the fact that it provides a natural glow without distorting facial features or making them appear out of proportion. Growing social media influence, high consciousness towards aesthetic appearance, and its association with self-confidence and self-image by an individual are some of the reasons for market growth.
Report Coverage
| Report Scope | Details |
| Market Size | US$ 2.2 billion by 2030 |
| Growth Rate | CAGR of 9.2% From 2022 to 2030 |
| Largest Market | North America |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Type, Gender, End use |
| Regional Scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa |
| Companies Mentioned | Allergan Plc; Gladerma; Merz Aesthetics; Bloomage Biotechnology; Teoxanne; Filorga; Professional Derma SA; IBSA – InstituteBiochemical SA (IBSA Derma) |
By Type Analysis
The mesotherapy segment dominated the market for skin boosters and accounted for the highest revenue share of 54.3% in 2021. Mesotherapy is a safer alternative to micro-needling and can deliver effective results as the penetration of needles in mesotherapy treatments goes deeper into the skin as compared to micro-needling.
Microneedling skin booster treatments have also been proven effective. However, the procedure requires multiple microscopic punctures on the surface of the skin. The treatment helps in generating new collagen and skin tissue for firmer, smoother, and more toned skin. It is mostly used on facial skin to treat large pores and scars.
By Gender Analysis
The female segment dominated the market for skin boosters and accounted for the largest revenue share of 85.0% in 2021. The segment is expected to expand remarkably by 2030. According to MedBeauty Australia, men have a higher density of collagen within their skin than women, implying that women tend to lose collagen faster as they age.
According to the International Society of Aesthetic Plastic Surgery, in 2019, out of the total aesthetic procedures carried out that year, women accounted for 88% and men accounted for 12%. However, the male population is inclining towards natural aesthetic treatments due to increasing social media influence and the desire to look perfect on social platforms.
By End-use Analysis
The medspa segment dominated the market for skin boosters and held the highest revenue share of 63.8% in 2021. The segment is also anticipated to reciprocate the highest growth over the forecast period. This is because Medspa provides aesthetic treatments under the supervision of a licensed medical practitioner.
Medspa’s currently uses innovative, cutting-edge technology, and products to provide clinical treatments that are in line with modern medicine. Currently, the millennial population is the largest target demographic for skin booster treatments.
The Association also states that the emergence of large medical spa chains, including Orange Twist, Beverly Hills Rejuvenation Centre, and Kalologie 360 are expected to further boost the market for skin boosters in the country.
By Regional Analysis
North America dominated the skin boosters market and held the largest revenue share of 38.9% in 2021 owing to the increasing demand for cosmetic procedures by both adults and the geriatric population.
In Asia Pacific, the market for skin boosters is projected to witness the highest CAGR of 10.4% during the forecast period. The region is backed by countries such as China, India, and Thailand. Growing focus towards the physical appearance in these developing countries is expected to play a key role in the demand for non-invasive aesthetic treatment.
Asian countries have been a long renowned hub for aesthetic procedures. Moreover, cost-effective and high-quality treatment, rising disposable income, and high incidence rate of skin conditions like atopic dermatitis and psoriasis are driving the market for skin boosters in the APAC region.
Read also @ Cardiovascular And Soft Tissue Repair Patches Market to Reach US$ 7.7 Bn by 2030
Major Key Players Covered in The Skin Boosters Market Report include
- Allergan Plc
- Gladerma
- Merz Aesthetics
- Bloomage Biotechnology
- Teoxanne
- Filorga
- Professional Derma SA
- IBSA – InstituteBiochemical SA (IBSA Derma)
Skin Boosters Market Segmentation
- By Type
- Mesotherapy
- Micro-needle
- By Gender
- Male
- Female
- By End-use
- Dermatology Clinics
- MedSpa
- Regional
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Latin America
- Mexico
- Brazil
- Argentina
- MEA
- South Africa
- Saudi Arabia
- UAE
- North America
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Skin Boosters Market, By Type
7.1. Skin Boosters Market, by Type, 2021-2030
7.1.1. Mesotherapy
7.1.1.1. Market Revenue and Forecast (2019-2030)
7.1.2. Micro-needle
7.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 8. Global Skin Boosters Market, By Gender
8.1. Skin Boosters Market, by Gender, 2021-2030
8.1.1. Male
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Female
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Skin Boosters Market, By End User
9.1. Skin Boosters Market, by End User, 2021-2030
9.1.1. Dermatology Clinics
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. MedSpa
9.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Skin Boosters Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.2. Market Revenue and Forecast, by Gender (2019-2030)
10.1.3. Market Revenue and Forecast, by End User (2019-2030)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.4.2. Market Revenue and Forecast, by Gender (2019-2030)
10.1.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.1.5.2. Market Revenue and Forecast, by Gender (2019-2030)
10.1.5.3. Market Revenue and Forecast, by End User (2019-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.2. Market Revenue and Forecast, by Gender (2019-2030)
10.2.3. Market Revenue and Forecast, by End User (2019-2030)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.4.2. Market Revenue and Forecast, by Gender (2019-2030)
10.2.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.5.2. Market Revenue and Forecast, by Gender (2019-2030)
10.2.5.3. Market Revenue and Forecast, by End User (2019-2030)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.6.2. Market Revenue and Forecast, by Gender (2019-2030)
10.2.6.3. Market Revenue and Forecast, by End User (2019-2030)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.2.7.2. Market Revenue and Forecast, by Gender (2019-2030)
10.2.7.3. Market Revenue and Forecast, by End User (2019-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.2. Market Revenue and Forecast, by Gender (2019-2030)
10.3.3. Market Revenue and Forecast, by End User (2019-2030)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.4.2. Market Revenue and Forecast, by Gender (2019-2030)
10.3.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.5.2. Market Revenue and Forecast, by Gender (2019-2030)
10.3.5.3. Market Revenue and Forecast, by End User (2019-2030)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.6.2. Market Revenue and Forecast, by Gender (2019-2030)
10.3.6.3. Market Revenue and Forecast, by End User (2019-2030)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.3.7.2. Market Revenue and Forecast, by Gender (2019-2030)
10.3.7.3. Market Revenue and Forecast, by End User (2019-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.2. Market Revenue and Forecast, by Gender (2019-2030)
10.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.4.2. Market Revenue and Forecast, by Gender (2019-2030)
10.4.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.5.2. Market Revenue and Forecast, by Gender (2019-2030)
10.4.5.3. Market Revenue and Forecast, by End User (2019-2030)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.6.2. Market Revenue and Forecast, by Gender (2019-2030)
10.4.6.3. Market Revenue and Forecast, by End User (2019-2030)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Type (2019-2030)
10.4.7.2. Market Revenue and Forecast, by Gender (2019-2030)
10.4.7.3. Market Revenue and Forecast, by End User (2019-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.2. Market Revenue and Forecast, by Gender (2019-2030)
10.5.3. Market Revenue and Forecast, by End User (2019-2030)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.4.2. Market Revenue and Forecast, by Gender (2019-2030)
10.5.4.3. Market Revenue and Forecast, by End User (2019-2030)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Type (2019-2030)
10.5.5.2. Market Revenue and Forecast, by Gender (2019-2030)
10.5.5.3. Market Revenue and Forecast, by End User (2019-2030)
Chapter 11. Company Profiles
11.1. Allergan Plc
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Gladerma
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Merz Aesthetics
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Bloomage Biotechnology
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Teoxanne
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Filorga
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Professional Derma SA
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. IBSA – InstituteBiochemical SA (IBSA Derma)
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Buy this Research Report study@ https://www.visionresearchreports.com/report/cart/39150
Contact Us:
Vision Research Reports
Call: +1 9197 992 333
